Inventor
HALEY JOHN D
US23 patents
⚠️ This page may combine multiple inventors who share the name “HALEY JOHN D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIEMENS MED SOLUTIONS HEALTH
6 patentsUS6948133B2Sep 20, 2005
System for dynamically configuring a user interface display
SIEMENS MED SOLUTIONS HEALTH149 citations97
US7246326B2Jul 17, 2007
System and procedure for providing a user interface display
SIEMENS MED SOLUTIONS HEALTH24 citations92
US6950831B2Sep 27, 2005
Processing system for use with a user interface display
SIEMENS MED SOLUTIONS HEALTH53 citations92
US6883144B2Apr 19, 2005
System supporting use of customizable expressions by applications
SIEMENS MED SOLUTIONS HEALTH24 citations88
US7334196B2Feb 19, 2008
User interface display navigation and item selection system
SIEMENS MED SOLUTIONS HEALTH21 citations86
US7054851B2May 30, 2006
Communication data format for use in data storage and retrieval
SIEMENS MED SOLUTIONS HEALTH18 citations84
HALEY JOHN D
4 patentsUS8093011B2Jan 10, 2012
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
HALEY JOHN D16 citations86
US8388957B2Mar 5, 2013
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
HALEY JOHN D0 citations50
US8062838B2Nov 22, 2011
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
HALEY JOHN D1 citations50
US9244058B2Jan 26, 2016
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
HALEY JOHN D0 citations45
ONCOGENE SCIENCE INC
3 patentsUS5824297AOct 20, 1998
Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
ONCOGENE SCIENCE INC25 citations92
US5635489AJun 3, 1997
Methods of prevention of oral mucositis with transforming growth factor β
ONCOGENE SCIENCE INC31 citations92
US5262319ANov 16, 1993
Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
ONCOGENE SCIENCE INC47 citations89
OSI PHARMACEUTICALS LLC
3 patentsUS8377636B2Feb 19, 2013
Biological markers predictive of anti-cancer response to kinase inhibitors
OSI PHARMACEUTICALS LLC7 citations82
US8383357B2Feb 26, 2013
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
OSI PHARMACEUTICALS LLC3 citations54
US8048621B2Nov 1, 2011
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
OSI PHARMACEUTICALS LLC1 citations50